|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
Opexa (OPXA) files $17.5 M offering
June 18, 2013
To fund further clinical development of Tcelna and the P2b study in patients with SPMS The history lesson: Prospectus is based on 7.99 M shares outstanding but excludes 1.11 M shares issuable upon... Read More
category
Henry McCusker
from Bio-Wire.Com
|